DNA vs GLUE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
DNA
GLUE
Investment Advisor Scores
GLUE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DNA | GLUE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 10.02 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -48.5% | -61.3% | DNA |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.5/100 | 44.7/100 | DNA |
| Profit Margin | -219.6% | 0.0% | GLUE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DNA
NeutralMixed signals - no dominant trend phase, RSI 46
GLUE
MarkdownPrice below a falling SMA50 (slope -21.9%), weak momentum, RSI 43
Fundamentals Snapshot
| Metric | DNA | GLUE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.4 | -6.0 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | -0.6% |
| Gross Margin | 0.7% | -4.7% |
| Operating Margin | -2.8% | -5.5% |
| EPS | -5.06 | -1.75 |
| Dividend Yield | — | — |